Infectious pathologists have praised a movement that will witness the sale of an effective drug to prevent HIV at only $ 40 annually in low -income countries. Dealms with Indian drug manufacturers will see public releases of the very effective Lenacapavir that were put in 120 countries as of 2027. Experts hope that the wider access to the drug means limiting the reduction of HIV. Story by Carys Garland.
[og_img]
Source link